Fig. 5

Development of the nomogram model and efficacy assessment. (A) Nomogram model for predicting IPAH risk based on the expression levels of COX6B1 and HMGCL. (B) Calibration curve of the nomogram model. (C) ROC curves evaluating the predictive performance of individual genes and nomogram model. (D) DCA for the nomogram model.